Karsivan vet 50 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

karsivan vet 50 mg

intervet international b.v. - propentofyllin - tablett, filmdrasjert - 50 mg

Panacur vet 222 mg/ g नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

panacur vet 222 mg/ g

intervet international b.v. - fenbendazol - granulat - 222 mg/ g

Vosevi यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitt c, kronisk - antivirale midler til systemisk bruk - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se kapittel 4. 2, 4. 4 og 5.

Slice vet 0.2 % w/w नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

slice vet 0.2 % w/w

intervet international bv - 5831 an - emamektinbenzoat - premiks til medisinert fôr - 0.2 % w/w

Vidalta vet 15 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

vidalta vet 15 mg

intervet international bv - 5831 an - karbimazol - depottablett - 15 mg

Vidalta vet 10 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

vidalta vet 10 mg

intervet international bv - 5831 an - karbimazol - depottablett - 10 mg

Biktarvy यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

biktarvy

gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - hiv-infeksjoner - antivirale midler til systemisk bruk - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se avsnitt 5.

Yescarta यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Vemlidy 25 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

vemlidy 25 mg

orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg

Genvoya नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

genvoya

orifarm as - elvitegravir / kobicistat / emtricitabin / tenofoviralafenamidfumarat - tablett, filmdrasjert - 150 mg / 150 mg / 200 mg / 10 mg